Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $1.6 million.

  • Burning Rock Biotech's Other Non-Current Liabilities rose 11414.84% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 11414.84%. This contributed to the annual value of $1.4 million for FY2024, which is 12382.45% up from last year.
  • Burning Rock Biotech's Other Non-Current Liabilities amounted to $1.6 million in Q3 2025, which was up 11414.84% from $1.5 million recorded in Q2 2025.
  • Burning Rock Biotech's 5-year Other Non-Current Liabilities high stood at $8.6 million for Q4 2021, and its period low was $35000.0 during Q1 2021.
  • In the last 5 years, Burning Rock Biotech's Other Non-Current Liabilities had a median value of $676000.0 in 2024 and averaged $1.7 million.
  • Per our database at Business Quant, Burning Rock Biotech's Other Non-Current Liabilities skyrocketed by 2436571.43% in 2021 and then crashed by 9301.65% in 2022.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Other Non-Current Liabilities stood at $8.6 million in 2021, then plummeted by 93.02% to $598000.0 in 2022, then increased by 6.69% to $638000.0 in 2023, then skyrocketed by 123.82% to $1.4 million in 2024, then increased by 9.17% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.5 million for Q2 2025, and $1.5 million during Q1 2025.